Information Technology Reference
In-Depth Information
3. Papaioannou A, Kennedy CC, Ioannidis G, Sawka A, Hopman WM, Pickard L, Brown JP,
Josse RG, Kaiser S, Anastassiades T, Goltzman D, Papadimitropoulos M, Tenenhouse A,
Prior JC, Olszynski WP, Adachi JD (2009) The impact of incident fractures on health-related
quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study. Osteoporos
Int 20(5):703
-
714
4. Ioannidis G, Papaioannou A, Hopman WM, Akhtar-Danesh N, Anastassiades T, Pickard L,
Kennedy CC, Prior JC, Olszynski WP, Davison KS, Goltzman D, Thabane L, Gafni A,
Papadimitropoulos EA, Brown JP, Josse RG, Hanley DA, Adachi JD (2009) Relation
between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study.
CMAJ 181(5):265
271
5. Jalava T, Sarna S, Pylkkanen L, Mawer B, Kanis JA, Selby P, Davies M, Adams J, Francis
RM, Robinson J, McCloskey E (2003) Association between vertebral fracture and increased
mortality in osteoporotic patients. J Bone Miner Res 18(7):1254
-
1260
6. Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR (2009) Mortality risk
associated with low-trauma osteoporotic fracture and subsequent fracture in men and women.
JAMA 301(5):513
-
521
7. Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV,
Jonsson B, Kanis JA (2013) Osteoporosis in the European Union: a compendium of country-
speci
c reports. Arch Osteoporos 8(1
-
2):137
8. Cauley JA (2013) Public health impact of osteoporosis. J Gerontol A Biol Sci Med Sci 68
(10):1243
-
1251
9. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence
and economic burden of osteoporosis-related fractures in the United States, 2005
-
2025.
-
475
10. WHO Study Group (1994) Assessment of fracture risk and its application to screening for
postmenopausal osteoporosis. Report of a WHO study group, World Health Organization
technical report series, pp 843:1
J Bone Miner Res 22(3):465
-
129
11. Schuit SC, van der Klift M, Weel AE, de Laet CE, Burger H, Seeman E, Hofman A,
Uitterlinden AG, van Leeuwen JP, Pols HA (2004) Fracture incidence and association with
bone mineral density in elderly men and women: the Rotterdam study. Bone 34(1):195
-
202
12. Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, Berger ML (2004)
Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch
Intern Med 164(10):1108
-
1112
13. Hopkins RB, Goeree R, Pullenayegum E, Adachi JD, Papaioannou A, Xie F, Thabane L
(2011) The relative ef
cacy of nine osteoporosis medications for reducing the rate of
fractures in post-menopausal women. BMC Musculoskelet Disord 12:209
14. Eriksen EF, Diez-Perez A, Boonen S (2013) Update on long-term treatment with
bisphosphonates for postmenopausal osteoporosis: a systematic review. Bone 58C:126
-
135
15. Kanis JA, Oden A, Johansson H, Borgstrom F, Strom O, McCloskey E (2009) FRAX and its
applications to clinical practice. Bone 44(5):734
-
743
16. Hillier TA, Cauley JA, Rizzo JH, Pedula KL, Ensrud KE, Bauer DC, Lui LY, Vesco KK,
Black DM, Donaldson MG, Leblanc ES, Cummings SR (2011) WHO absolute fracture risk
models (FRAX): do clinical risk factors improve fracture prediction in older women without
osteoporosis? J Bone Miner Res 26(8):1774
-
1782
17. Delmas PD, Munoz F, Black DM, Cosman F, Boonen S, Watts NB, Kendler D, Eriksen EF,
Mesenbrink PG, Eastell R (2009) Effects of yearly zoledronic acid 5 mg on bone turnover
markers and relation of PINP with fracture reduction in postmenopausal women with
osteoporosis. J Bone Miner Res 24(9):1544
-
1551
18. Lee J, Vasikaran S (2012) Current recommendations for laboratory testing and use of bone
turnover markers in management of osteoporosis. Ann Lab Med 32(2):105
-
112
19. Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, Licata A, Benhamou L,
Geusens P, Flowers K, Stracke H, Seeman E (2001) Risk of new vertebral fracture in the year
following a fracture. JAMA 285(3):320
-
323
-
